Clincosm LogoSign in Get a demo

primary hypercholesterolemia

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)

Not yet recruiting
  • Essential Hypertension
  • Primary Hypercholesterolemia
  • Seoul, Korea, Republic of
    Severance Hospital
Jun 26, 2023

Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe

Not yet recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Bempedoic acid and/or its fixed dose combination with ezetimibe
  • (no location specified)
Mar 23, 2023

Primary Hypercholesterolemia Trial in Seoul (D377, CKD-331, D086)

Recruiting
  • Primary Hypercholesterolemia
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 12, 2022

Inclisiran Plus Standard of Care Lipid-lowering Therapy Compared

Recruiting
  • Primary Hypercholesterolemia
  • Mixed Dyslipidemia
  • Inclisiran
  • Geneve 14, Switzerland
    Novartis Investigative Site
Nov 14, 2022

Efficacy of Fixed Dose Combination Therapy With Atorvastatin and

Enrolling by invitation
  • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Nov 4, 2022

    Primary Hypercholesterolemia Trial in Seoul (AD-221, AD-221A, AD-221B)

    Completed
    • Primary Hypercholesterolemia
    • Seoul, Seodaemun-gu, Korea, Republic of
      Yonsei University Hospital
    Jul 19, 2022

    Inclisiran in Chinese Adult Primary Hypercholesterolemia or

    Recruiting
    • Primary Hypercholesterolemia
    • Mixed Dyslipidemia
    • Inclisiran
    • Haikou, Hainan, China
    • +2 more
    Jun 13, 2022

    Primary Hypercholesterolemia, Mixed Hyperlipemia Trial in Guangzhou (SHR-1209, SHR-1209 Placebo)

    Active, not recruiting
    • Primary Hypercholesterolemia
    • Mixed Hyperlipemia
    • Guangzhou, Guangzhou, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jun 9, 2022

    Primary Hypercholesterolemia, Mixed Dyslipidemias Trial in Australia, New Zealand, Taiwan (Pitavastatin, Ezetimibe, 1PC111)

    Completed
    • Primary Hypercholesterolemia
    • Mixed Dyslipidemias
    • Blacktown, Australia
    • +33 more
    May 17, 2022

    Primary Hypercholesterolemia Trial in Guangzhou (SHR-1209, SHR-1209 Placebo)

    Active, not recruiting
    • Primary Hypercholesterolemia
    • Guangzhou, Guangzhou, China
      Guangdong Provincial People's Hospital
    May 15, 2022

    Primary Hypercholesterolemia Trial in Guangzhou (Lactobacillus paracasei dietary supplement, Placebo controls)

    Active, not recruiting
    • Primary Hypercholesterolemia
    • Lactobacillus paracasei dietary supplement
    • Placebo controls
    • Guangzhou, Guangdong, China
      Department of Nutrition and Food Hygiene
    May 3, 2022

    Primary Hypercholesterolemia Trial (Ezetimibe, Atorvastatin, Rosuvastatin)

    Completed
    Has Results
    • Primary Hypercholesterolemia
    • (no location specified)
    Feb 7, 2022

    Ezetimibe onSelect Population of Filipinos With

    Completed
    Has Results
    • Primary Hypercholesterolemia
    • Homozygous Familial Hypercholesterolemia
    • (no location specified)
    Feb 7, 2022

    Percentage of Reached Their LDL-C Objectives After Treatment

    Completed
    Has Results
    • Primary Hypercholesterolemia
    • (no location specified)
    Feb 7, 2022

    Primary Hypercholesterolemia Trial in Seoul (AGT2, AGZ, AGT2, AGT4, AGZ)

    Recruiting
    • Primary Hypercholesterolemia
    • AGT2, AGZ
    • +3 more
    • Seoul, Korea, Republic of
      Yonsei severance Hospital
    Jan 12, 2022

    Primary Hypercholesterolemia Trial in Seoul (Livalo, Ezetrol)

    Completed
    • Primary Hypercholesterolemia
    • Livalo, Ezetrol
    • Seoul, Korea, Korea, Republic of
      Gangdong Sacred Heart Hospital
    Nov 29, 2021

    Primary Hypercholesterolemia, Mixed Dyslipidemia Trial in China (evolocumab, )

    Terminated
    Has Results
    • Primary Hypercholesterolemia
    • Mixed Dyslipidemia
    • Beijing, Beijing, China
    • +30 more
    Oct 7, 2021

    Primary Hypercholesterolemia Trial in Seoul (HGP1910, HCP1903, HGP1909)

    Completed
    • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Asan Medical Center
    Mar 4, 2021

    Primary Hypercholesterolemia, Hypertension Trial in Daegu (Experimental : Ezetimibe / Rosuvastatin + Telmisartan, Active

    Recruiting
    • Primary Hypercholesterolemia
    • Hypertension
    • Experimental : Ezetimibe / Rosuvastatin + Telmisartan
    • +2 more
    • Daegu, Korea, Republic of
      Daegu Catholic Univ Medical Center
    Dec 2, 2020

    Primary Hypercholesterolemia, Mixed Dyslipidemia Trial (Comparator: simvastatin, MK-0524A, Placebo)

    Completed
    Has Results
    • Primary Hypercholesterolemia
    • Mixed Dyslipidemia
    • Comparator: simvastatin
    • +3 more
    • (no location specified)
    Jan 17, 2019

    Primary Hypercholesterolemia, Mixed Dyslipidemia Trial in Canada, United States (Evolocumab Pre-filled Syringe, Evolocumab

    Completed
    Has Results
    • Primary Hypercholesterolemia
    • Mixed Dyslipidemia
    • Evolocumab Pre-filled Syringe
    • Evolocumab AI/pen
    • Encino, California
    • +25 more
    Nov 1, 2018

    Primary Hypercholesterolemia Trial (HS-25 10mg, HS-25 10mg combination with Atorvastatin, HS-25 20mg combination with

    Unknown status
    • Primary Hypercholesterolemia
    • HS-25 10mg
    • +5 more
    • (no location specified)
    Oct 17, 2018

    Primary Hypercholesterolemia Trial (HS-25, Placebo of HS-25)

    Completed
    • Primary Hypercholesterolemia
    • (no location specified)
    Oct 17, 2018

    Primary Hypercholesterolemia Trial (HL140 5/10, HL140 10/10, HL140 20/10)

    Completed
    • Primary Hypercholesterolemia
    • HL140 5/10
    • +5 more
    • (no location specified)
    Aug 12, 2018

    Generic Rosuvastatin in a Real-world Setting

    Completed
    • Primary Hypercholesterolemia
    • (no location specified)
    Apr 24, 2018